Developer docs
API playgroundTry for free, no card

Search company profiles

Ashermed

Full company profile

uuid0003d63

Namestring
Ashermed
Legal namestring
上海艾莎医学科技有限公司
Websiteurl
ashermed.com
Company typeenum
Private
Founded yearint
2011
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersShanghai, China
HQ citystring
Shanghai
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research services, digital clinical CRO, clinical trial management, electronic data capture, patient recruitment services
Industry4 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
NAICS code1 code
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code1 code
  • Services-Engineering, Accounting, Research, Management8700
Product category
Clinical Research Organization (CRO) Services
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model5 records
1CRO Services
TypeProfessional Services
Description

Contract Research Organization services providing comprehensive clinical research support including protocol design, site management, monitoring, and data management.

ashermed.com
2SMO Services
TypeProfessional Services
Description

Site Management Organization services for on-site clinical trial support and site coordination.

ashermed.com
3Patient Recruitment Services
TypeProfessional Services
Description

Patient screening, recruitment, aid, education, and follow-up services. Includes rare disease patient management platforms.

ashermed.com
4Digital Platform Services
TypeSubscription Recurring
Description

Digital clinical research platform software and technology services including SSU (Site Start-Up), DCT (Decentralized Clinical Trials), and integrated hospital system connections.

ashermed.com
5Medical Value Communication
TypeProfessional Services
Description

Evidence-based medical value communication services for pharmaceutical and medical device product lifecycle management, including CME, KOL interviews, case studies, and guideline training.

ashermed.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Ashermed (艾莎医学) is an innovative digital clinical Contract Research Organization (CRO) providing comprehensive clinical research services for pharmaceutical and medical device companies in China. The company delivers CRO, SMO, patient recruitment, and digital platform support services through a self-developed digital product matrix (eProtocol, EDC, CTMS, ePRO) backed by AI-powered medical knowledge graph and multi-modal data processing capabilities.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 70% reduction in project manual labor investment
+5 more records
Product and service12 records
1eProtocol Digital Protocol Design System (eProtocol方案设计系统)
CategoryDigital Clinical Trial Software
2EDC Electronic Data Capture System (EDC电子数据采集系统)
CategoryDigital Clinical Trial Software
3CTMS Clinical Trial Management System (CTMS临床试验项目管理系统)
CategoryDigital Clinical Trial Software
4ePRO Electronic Patient-Reported Outcome System (ePRO患者电子报告系统)
CategoryDigital Clinical Trial Software
5CRO Services (CRO服务)
CategoryCRO Services
6SMO Services (SMO服务)
CategoryCRO Services
7Patient Recruitment Services (患者招募服务)
CategoryCRO Services
8Digital Platform Support (数字化平台支持)
CategoryDigital Clinical Trial Software
9Hepatology Academy (肝病学苑)
CategorySpecialized Disease Platform
10iHemater Hematology Cloud Expert (iHemater血液病云专家)
CategorySpecialized Disease Platform
11Jianyu Mutual Aid Home (渐愈互助之家)
CategorySpecialized Disease Platform
12Medical Value Communication Services
CategoryMedical Communication Services
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership19 partners
1Beijing Friendship Hospital (首都医科大学附属北京友谊医院)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-09-27
Description

Joint development of clinical research digital management platform to improve research efficiency and quality through system integration.

ashermed.com
2Shanxi Bethune Hospital Clinical Trial Institution (山西白求恩医院临床试验机构)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-07-20
Description

Strategic cooperation for clinical research collaboration, leveraging hospital's clinical trial infrastructure and Ashermed's digital platform capabilities.

ashermed.com
3Guangdong Province Zhong Nanshan Medical Foundation (广东省钟南山医学基金会)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-01-05
Description

Strategic partnership to leverage digital AI capabilities for efficient scientific research and public welfare project management.

ashermed.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Jointly established rare disease patient management platform. Successfully gathered over 6,000 verified ALS patients within one year and completed patient recruitment for four ALS clinical trials.

5Peking Union Medical College Hospital (北京协和医院)
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Leading academic medical center partnership for clinical research collaboration.

ashermed.com
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Top-tier teaching hospital partnership for multi-center clinical research.

7Wuhan Union Hospital (武汉协和医院)
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Major tertiary hospital partnership for clinical research collaboration.

ashermed.com
8Shanghai Ruijin Hospital (上海瑞金医院)
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Leading Shanghai-based teaching hospital partnership for clinical research.

ashermed.com
9Chinese Foundation for Hepatitis Prevention and Control (中国肝炎防治基金会)
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Foundation partnership for hepatitis prevention and control research projects.

ashermed.com
10Bethune Charitable Foundation (白求恩公益基金会)
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Charitable foundation partnership for clinical research and public welfare projects.

ashermed.com
11Wu Jieping Medical Foundation (吴阶平医学基金会)
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Medical foundation partnership supporting clinical research initiatives.

ashermed.com
12China Medical and Health Development Foundation (中国医药卫生事业发展基金会)
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Foundation partnership for medical and health development projects.

ashermed.com
Strategic tierKey ClientTypeOthers
Description

Global pharmaceutical company served as a client for clinical research services.

Strategic tierKey ClientTypeOthers
Description

Global pharmaceutical company served as a client for clinical research services.

Strategic tierKey ClientTypeOthers
Description

Global pharmaceutical company served as a client for clinical research services.

Strategic tierKey ClientTypeOthers
Description

Japanese pharmaceutical company served as a client for clinical research services.

Strategic tierKey ClientTypeOthers
Description

Global pharmaceutical company served as a client for clinical research services.

18Hengrui Medicine (恒瑞医药)
Strategic tierKey ClientTypeOthers
Description

Leading domestic pharmaceutical company served as a client for clinical research services.

ashermed.com
Strategic tierKey ClientTypeOthers
Description

Global oncology-focused biotech company served as a client for clinical research services.

Peers10 records
TypeDirect peer
Description

Hangzhou Tigermed is the largest China-headquartered clinical CRO offering full-service Phase I-IV clinical trial management, biostatistics, and site management. Direct competitor for the same multinational and domestic pharma clients in China, with broader scale and global footprint.

TypeBroad incumbent
Description

WuXi AppTec is a global CRO/CDMO with extensive clinical research services in China and worldwide. It is a broader incumbent whose clinical CRO business competes directly with Ashermed for pharma sponsors, while also offering preclinical, manufacturing, and biologics services.

TypeBroad incumbent
Description

Pharmaron is a China-based, globally integrated CRO/CDMO offering laboratory, CMC, and clinical research services. It competes with Ashermed for China-based clinical trial work while operating a much broader service portfolio.

TypeDirect peer
Description

Frontage is a US-China clinical CRO providing bioanalytical, CMC, and clinical research services with a strong China footprint. Comparable in mid-tier clinical CRO positioning and overlap with Ashermed in pharma/biotech sponsors.

TypeBroad incumbent
Description

ICON is one of the world's largest clinical CROs offering full-service Phase I-IV trial management, decentralized trials, and real-world evidence globally. It is a broader incumbent whose digital trial capabilities overlap with Ashermed's positioning.

TypeBroad incumbent
Description

IQVIA is the largest global clinical CRO and life sciences data/technology provider. It competes with Ashermed for global pharma clinical work in China and offers overlapping decentralized trial, real-world evidence, and AI-enabled data services.

TypeDirect peer
Description

Medpace is a mid-size, science-focused global clinical CRO known for full-service trial execution across multiple therapeutic areas. Comparable in its lean, technology-enabled CRO operating model and overlap with Ashermed in mid-cap pharma sponsors.

TypeBroad incumbent
Description

Charles River is a global CRO/CDMO with clinical trial services spanning early-phase through post-marketing. It is a broader incumbent whose China clinical research operations compete with Ashermed, particularly for multinational sponsors.

TypeBroad incumbent
Description

Parexel is a global clinical CRO serving pharma and biotech sponsors across Phase I-IV and post-approval studies. It competes with Ashermed for multinational clinical work, including in China, with a broader service portfolio.

TypeRegional player
Description

Novotech is an Asia-Pacific-focused clinical CRO with strong presence in China, Australia, and South Korea. It is a regional peer competing for similar biotech sponsors running trials in Asia, with comparable mid-tier CRO positioning to Ashermed.

Market position
Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ashermed

Clinical Research Organization (CRO) Servicesashermed.com

Ashermed firmographics

Firmographics
Name
Ashermed
Legal name
上海艾莎医学科技有限公司
Website
https://ashermed.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Ashermed industry classification

Industry
Product category
Clinical Research Organization (CRO) Services
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Engineering, Accounting, Research, Management (8700)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs

Keywords

  • Clinical research services
  • Digital clinical CRO
  • Clinical trial management
  • Electronic data capture
  • Patient recruitment services

Where Ashermed is headquartered

Location

Headquarters

HQ city
Shanghai
HQ country
China
HQ region
Asia

Offices4 records

Markets served

Ashermed business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. CRO Services: Contract Research Organization services providing comprehensive clinical research support including protocol design, site management, monitoring, and data management.
  2. SMO Services: Site Management Organization services for on-site clinical trial support and site coordination.
  3. Patient Recruitment Services: Patient screening, recruitment, aid, education, and follow-up services. Includes rare disease patient management platforms.
  4. Digital Platform Services: Digital clinical research platform software and technology services including SSU (Site Start-Up), DCT (Decentralized Clinical Trials), and integrated hospital system connections.
  5. Medical Value Communication: Evidence-based medical value communication services for pharmaceutical and medical device product lifecycle management, including CME, KOL interviews, case studies, and guideline training.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Ashermed product offering

Product offering

Core offering

Ashermed (艾莎医学) is an innovative digital clinical Contract Research Organization (CRO) providing comprehensive clinical research services for pharmaceutical and medical device companies in China. The company delivers CRO, SMO, patient recruitment, and digital platform support services through a self-developed digital product matrix (eProtocol, EDC, CTMS, ePRO) backed by AI-powered medical knowledge graph and multi-modal data processing capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

  • eProtocol Digital Protocol Design System (eProtocol方案设计系统)
  • EDC Electronic Data Capture System (EDC电子数据采集系统)
  • CTMS Clinical Trial Management System (CTMS临床试验项目管理系统)
  • ePRO Electronic Patient-Reported Outcome System (ePRO患者电子报告系统)
  • CRO Services (CRO服务)
  • SMO Services (SMO服务)
  • Patient Recruitment Services (患者招募服务)
  • Digital Platform Support (数字化平台支持)
  • Hepatology Academy (肝病学苑)
  • iHemater Hematology Cloud Expert (iHemater血液病云专家)
  • Jianyu Mutual Aid Home (渐愈互助之家)
  • Medical Value Communication Services

Quantifiable outcome

  • 70% reduction in project manual labor investment
  • +5 more outcomes

Companies that use Ashermed

Customer profile

Named customers11 records

Segments4 records

Ideal customer profiles3 records

Ashermed technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability7 records

Feature7 records

Ashermed partnerships and signals

Strategic signal

Partnerships

19 partnerships are on record, tiered core, major and key client.

  • Beijing Friendship Hospital (首都医科大学附属北京友谊医院)coreStrategic or Co-development Partner · 27 September 2022Joint development of clinical research digital management platform to improve research efficiency and quality through system integration.
  • Shanxi Bethune Hospital Clinical Trial Institution (山西白求恩医院临床试验机构)coreStrategic or Co-development Partner · 20 July 2022Strategic cooperation for clinical research collaboration, leveraging hospital's clinical trial infrastructure and Ashermed's digital platform capabilities.
  • Guangdong Province Zhong Nanshan Medical Foundation (广东省钟南山医学基金会)coreStrategic or Co-development Partner · 5 January 2022Strategic partnership to leverage digital AI capabilities for efficient scientific research and public welfare project management.
  • JD Group (京东集团)coreStrategic or Co-development PartnerJointly established rare disease patient management platform. Successfully gathered over 6,000 verified ALS patients within one year and completed patient recruitment for four ALS clinical trials.
  • Peking Union Medical College Hospital (北京协和医院)majorStrategic or Co-development PartnerLeading academic medical center partnership for clinical research collaboration.
  • West China Hospital of Sichuan University (四川大学华西医院)majorStrategic or Co-development PartnerTop-tier teaching hospital partnership for multi-center clinical research.
  • Wuhan Union Hospital (武汉协和医院)majorStrategic or Co-development PartnerMajor tertiary hospital partnership for clinical research collaboration.
  • Shanghai Ruijin Hospital (上海瑞金医院)majorStrategic or Co-development PartnerLeading Shanghai-based teaching hospital partnership for clinical research.
  • Chinese Foundation for Hepatitis Prevention and Control (中国肝炎防治基金会)majorStrategic or Co-development PartnerFoundation partnership for hepatitis prevention and control research projects.
  • Bethune Charitable Foundation (白求恩公益基金会)majorStrategic or Co-development PartnerCharitable foundation partnership for clinical research and public welfare projects.
  • Wu Jieping Medical Foundation (吴阶平医学基金会)majorStrategic or Co-development PartnerMedical foundation partnership supporting clinical research initiatives.
  • China Medical and Health Development Foundation (中国医药卫生事业发展基金会)majorStrategic or Co-development PartnerFoundation partnership for medical and health development projects.
  • Pfizer (辉瑞)key clientOthersGlobal pharmaceutical company served as a client for clinical research services.
  • Roche (罗氏)key clientOthersGlobal pharmaceutical company served as a client for clinical research services.
  • Novartis (诺华)key clientOthersGlobal pharmaceutical company served as a client for clinical research services.
  • Takeda (武田制药)key clientOthersJapanese pharmaceutical company served as a client for clinical research services.
  • Eli Lilly (礼来)key clientOthersGlobal pharmaceutical company served as a client for clinical research services.
  • Hengrui Medicine (恒瑞医药)key clientOthersLeading domestic pharmaceutical company served as a client for clinical research services.
  • BeiGene (百济神州)key clientOthersGlobal oncology-focused biotech company served as a client for clinical research services.

Scale indicators9 records

Ashermed competitors and assessment

Company assessment

Direct peers

  • Tigermed (Hangzhou Tigermed Consulting): Hangzhou Tigermed is the largest China-headquartered clinical CRO offering full-service Phase I-IV clinical trial management, biostatistics, and site management. Direct competitor for the same multinational and domestic pharma clients in China, with broader scale and global footprint.
  • Frontage Holdings: Frontage is a US-China clinical CRO providing bioanalytical, CMC, and clinical research services with a strong China footprint. Comparable in mid-tier clinical CRO positioning and overlap with Ashermed in pharma/biotech sponsors.
  • Medpace: Medpace is a mid-size, science-focused global clinical CRO known for full-service trial execution across multiple therapeutic areas. Comparable in its lean, technology-enabled CRO operating model and overlap with Ashermed in mid-cap pharma sponsors.

Broad incumbents

  • WuXi AppTec: WuXi AppTec is a global CRO/CDMO with extensive clinical research services in China and worldwide. It is a broader incumbent whose clinical CRO business competes directly with Ashermed for pharma sponsors, while also offering preclinical, manufacturing, and biologics services.
  • Pharmaron: Pharmaron is a China-based, globally integrated CRO/CDMO offering laboratory, CMC, and clinical research services. It competes with Ashermed for China-based clinical trial work while operating a much broader service portfolio.
  • ICON plc: ICON is one of the world's largest clinical CROs offering full-service Phase I-IV trial management, decentralized trials, and real-world evidence globally. It is a broader incumbent whose digital trial capabilities overlap with Ashermed's positioning.
  • IQVIA: IQVIA is the largest global clinical CRO and life sciences data/technology provider. It competes with Ashermed for global pharma clinical work in China and offers overlapping decentralized trial, real-world evidence, and AI-enabled data services.
  • Charles River Laboratories: Charles River is a global CRO/CDMO with clinical trial services spanning early-phase through post-marketing. It is a broader incumbent whose China clinical research operations compete with Ashermed, particularly for multinational sponsors.
  • Parexel: Parexel is a global clinical CRO serving pharma and biotech sponsors across Phase I-IV and post-approval studies. It competes with Ashermed for multinational clinical work, including in China, with a broader service portfolio.

Regional players

  • Novotech (Novotech Health Holdings): Novotech is an Asia-Pacific-focused clinical CRO with strong presence in China, Australia, and South Korea. It is a regional peer competing for similar biotech sponsors running trials in Asia, with comparable mid-tier CRO positioning to Ashermed.

Market position

Customer concentration

Ashermed compliance and trust

Trust signal

Compliance4 records

Ashermed financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ashermed leadership team

Management profile

Number of profiles

Ashermed funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ashermed M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ashermed

What does Ashermed do?

Ashermed (艾莎医学) is an innovative digital clinical Contract Research Organization (CRO) providing comprehensive clinical research services for pharmaceutical and medical device companies in China. The company delivers CRO, SMO, patient recruitment, and digital platform support services through a self-developed digital product matrix (eProtocol, EDC, CTMS, ePRO) backed by AI-powered medical knowledge graph and multi-modal data processing capabilities.

Is Ashermed a public or private company?

Ashermed is a private company. It is classified as venture growth investor backed and is currently operating.

When was Ashermed founded?

Ashermed was founded in 2011. It employs 1 to 10 people.

Where is Ashermed based?

Ashermed is headquartered in Shanghai, China, in the Asia region.

How does Ashermed make money?

Five revenue lines are on record. CRO Services are the primary driver. The others are SMO Services, patient Recruitment Services, digital Platform Services and medical Value Communication.

Who are Ashermed's main competitors?

Direct peers on record are Tigermed (Hangzhou Tigermed Consulting), Frontage Holdings and Medpace. Broad incumbents are WuXi AppTec, Pharmaron, ICON plc, IQVIA, Charles River Laboratories and Parexel. Novotech (Novotech Health Holdings) is listed as a regional player.

Does Ashermed have an API?

No public API is recorded for Ashermed.

What industry is Ashermed in?

Ashermed's product category is Clinical Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 54171 and its SIC code is 8700.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales